Related Experiment Video
Updated: May 16, 2026

Humanized Mediator Release Assay as a Read-Out for Allergen Potency
Published on: June 29, 2021
Type 1 Ig-E mediated allergy to human insulin, insulin analogues and beta-lactam antibiotics
Pedro Andrade1, Luísa Barros, Margarida Gonçalo
1Dermatology and Venereology Service, Teaching Hospitals of University of Coimbra (Universidade de Coimbra, EPE) - Coimbra, Portugal. pedro.andrade@portugalmail.com
Abstract:
Insulin, a crucial therapeutic agent for diabetes mellitus, has been rarely associated with hypersensitivity events. We present a 69-year-old type-2 diabetic patient with urticariform lesions on the sites of subcutaneous injection of insulin. The patient denied any known allergies, except for an unspecific cutaneous reaction after intramuscular penicillin administration in childhood. Prick tests revealed positive reactions to all tested human insulins and insulin analogues. Serum IgE levels were above normal range and RAST tests were positive for human, bovine and porcine insulins, as well as beta-lactams. Type 1 IgE-mediated allergy to insulin analogues demands a prompt diagnosis and represents a significant therapeutic challenge in diabetic patients.
Related Concept Videos
Allergic Drug Reactions
Drug Toxicity: Allergic Reactions
Type I Diabetes I: Introduction
Allergic Reactions: Anaphylaxis
Type I Diabetes II: Pathophysiology
Hypersensitivities
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...

